This was a fairly small study and a lot of questions remain to be answered, including whether GLP-1 agonists could help people with more advanced Parkinsons, halt the progression of Parkinsons motor symptoms over a longer period, or prevent other types of symptoms, such as ones related to cognition, from worsening
It does, but not just any old amino acids
IGF-1 receptor density begins declining after 68 weeks of continuous ligand exposure due to negative feedback mechanisms that downregulate receptor transcription extending cycles beyond this point produces diminishing returns where the same dose generates progressively weaker mTOR activation
Quality and safety: This product is approved by Food and Agriculture Ministry, Manufacturer Approval Code: TR-43- K -268986
GLP-1 drugs are generally safe to use, but they can cause side effects, such as nausea, vomiting, diarrhea, and constipation
The cumulative annual cost often reaches $2,000-3,500 depending on frequency and clinic pricing